跳至主要内容
临床试验/EUCTR2012-000775-17-ES
EUCTR2012-000775-17-ES进行中(未招募)不适用

A comparative, randomised controlled trial for evaluating the efficacy of dexamethasone administration in the treatment of patients with the Acute Respiratory Distress Syndrome

Jesús Villar Hernández0 个研究点开始时间: 2012年7月19日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • To be eligible for inclusion into this study (Day 0), each patient must fulfil the following inclusion criteria during screening and prior to the enrolment into the study:
  • a.Age >=18 years old
  • b.Patients must have acute onset of ARDS, as defined by the American-European Consensus Conference (AECC) criteria for ARDS:
  • i.Having an initiating clinical condition (pneumonia, aspiration, inhalation injury, sepsis, trauma, acute pancreatitis, etc.).
  • ii.bilateral infiltrates on frontal chest radiograph
  • iii.absence of left atrial hypertension, a pulmonary capillary wedge pressure (PCWP) less than 18 mm Hg, or no clinical signs of left heart failure
  • iv.severe hypoxemia (a PaO2/FIO2 <=200 mm Hg, regardless of FIO2 or positive end-expiratory pressure (PEEP)
  • c.Be intubated and mechanically ventilated
  • d.Have provided signed written informed consent from the patient or the patient's personal legal representative.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 264
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 50

排除标准

  • To be eligible for inclusion into this study (Day 0), each patient must not have any of the following exclusion criteria during screening and prior to the enrolment into the study:
  • e.Be a woman known to be pregnant or lactating
  • f.Take part in another experimental treatment protocol (simultaneously)
  • g.Brain death
  • h.Terminal-stage cancer or other terminal disease
  • i.Having do-not-resuscitate orders
  • j.Being immune-compromised
  • k.Receiving corticosteroids or immunosuppressive drugs
  • l.Patients in whom more than 24 hours had elapsed after initially meeting the AECC ARDS criteria before consent and results of initial standard ventilator settings could be obtained.
  • m.Have severe chronic obstructive pulmonary disease (COPD)
  • n.Have congestive heart failure

研究者

发起方
Jesús Villar Hernández

相似试验

A comparative, randomised controlled trial for... | 临床试验